Related Experiment Video
Updated: Jun 26, 2026

Creation and Transplantation of an Adipose-derived Stem Cell (ASC) Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer
Yue Cao1, Xiaokun Gang1, Chenglin Sun1
1Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun 130021, China.
Abstract:
Mesenchymal stem cells (MSCs), an ideal cell source for regenerative therapy with no ethical issues, play an important role in diabetic foot ulcer (DFU). Growing evidence has demonstrated that MSCs transplantation can accelerate wound closure, ameliorate clinical parameters, and avoid amputation. In this review, we clarify the mechanism of preclinical studies, as well as safety and efficacy of clinical trials in the treatment of DFU. Bone marrow-derived mesenchymal stem cells (BM-MSCs), compared with MSCs derived from other tissues, may be a suitable cell type that can provide easy, effective, and cost-efficient transplantation to treat DFU and protect patients from amputation.
Related Concept Videos
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...
Diabetic Foot Ulcer

